Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
25.59
-0.29 (-1.12%)
Nov 6, 2026, 10:24 AM CST

SHA:603590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
429.47332.57189.98230.2345.25599.08
Short-Term Investments
-136.3953.82183.820.7510.81
Trading Asset Securities
370.3500.43450.66396.41280.379.04
Cash & Short-Term Investments
799.76969.39694.46810.43626.36618.93
Cash Growth
-12.98%39.59%-14.31%29.39%1.20%-59.49%
Accounts Receivable
279.86278.09257.38282.83296.39244.38
Other Receivables
78.4376.0733.8435.5627.736.31
Receivables
358.29354.16291.22318.39324.13250.69
Inventory
7054.4772.3848.4736.9947.02
Other Current Assets
118.8317.5128.4852.6729.2331.19
Total Current Assets
1,3471,3961,0871,2301,017947.83
Property, Plant & Equipment
398.39404.15426.73414.54440.14407.06
Long-Term Investments
1,0011,0781,249984.45927.15695.95
Goodwill
---97.6497.6497.64
Other Intangible Assets
826.7833.37842.67854.64812.75815.17
Long-Term Deferred Tax Assets
9.1921.3627.4732.271.098.96
Long-Term Deferred Charges
357.32308234.36150.71120.4582.41
Other Long-Term Assets
175.7454.9153.3116.68.87316.3
Total Assets
4,1154,0953,9203,7813,4253,371

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
18.6731.273.5782.9748.4746.74
Accrued Expenses
38.6858.2745.6832.1526.8233.99
Short-Term Debt
282.44253.45140.9696.93--
Current Portion of Long-Term Debt
64.422.641.075.12--
Current Portion of Leases
-6.6173.958.717.5
Current Income Taxes Payable
11.540.714.690.2534.1215.84
Current Unearned Revenue
2.4355.956.436.492.921.2
Other Current Liabilities
104.1750.6273.2995.5351.3249.49
Total Current Liabilities
522.35459.45352.68323.39172.36154.77
Long-Term Debt
33.2654.2849.8543.78--
Long-Term Leases
1.063.1710.8-3.7111.12
Long-Term Unearned Revenue
38.0441.8740.4823.4928.9829.83
Long-Term Deferred Tax Liabilities
37.5839.7439.7227.7829.6245.02
Total Liabilities
632.29598.51493.52418.44234.68240.74

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
161.29159.01159.36160160160
Additional Paid-In Capital
987.16948.77944.6955.01992.46985.17
Retained Earnings
2,1602,1152,0452,0501,9311,876
Treasury Stock
-113.69-32.86-35.93-78.59-124.64-124.64
Comprehensive Income & Other
-1.9221.1431.8-26.5-32.8-8.11
Total Common Equity
3,1933,2113,1443,0602,9262,889
Minority Interest
289.6285.21281.75302.44264.22241.81
Shareholders' Equity
3,4833,4963,4263,3623,1903,131
Total Liabilities & Equity
4,1154,0953,9203,7813,4253,371

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
381.18320.16209.67149.7812.4218.62
Net Cash (Debt)
418.59649.23484.79660.65613.94600.31
Net Cash Growth
-34.46%33.92%-26.62%7.61%2.27%-60.08%
Net Cash Per Share
2.624.073.104.223.933.81
Filing Date Shares Outstanding
153.97157.53159.22158.98156.49156.49
Total Common Shares Outstanding
153.97158.61158.83158.98156.49156.49
Working Capital
824.53936.08733.86906.57844.35793.06
Book Value Per Share
20.7420.2519.8019.2518.7018.46
Tangible Book Value
2,3662,3782,3022,1082,0161,976
Tangible Book Value Per Share
15.3714.9914.4913.2612.8812.63
Buildings
-404.81324.61322.64323.38322.3
Machinery
-181.48126.83125.74126.76114.72
Construction In Progress
-81.73209.85190.8181.98127.26